clavulanic acid has been researched along with cefotaxime in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (11.70) | 18.7374 |
1990's | 20 (21.28) | 18.2507 |
2000's | 39 (41.49) | 29.6817 |
2010's | 21 (22.34) | 24.3611 |
2020's | 3 (3.19) | 2.80 |
Authors | Studies |
---|---|
Azaripour, A; Hakimelahi, GH; Hwu, JR; Lin, CC; Moshfegh, AA; Mottaghian, H; Tsay, SC; Tseng, WN | 1 |
Bonnet, R; Chanal, C; Delmas, J; Lesens, O; Robin, F; Schweitzer, C; Tournilhac, O | 1 |
Aubert, D; Naas, T; Nordmann, P; Ozcan, A | 1 |
Arlet, G; Loli, A; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Cattoir, V; Corvec, S; Drugeon, H; Faccone, D; Galas, M; Mugnier, P; Nordmann, P; Pasteran, F; Petroni, A; Poirel, L; Rapoport, M | 1 |
Bush, K; Kania, M; Page, MG; Queenan, AM; Shang, W | 1 |
Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Bonnet, R; Brebion, A; Constantin, JM; Delmas, J; Dubois, D; Robin, F | 1 |
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J | 1 |
Bonnet, R; Neuwirth, C; Robin, F; Siebor, E | 1 |
Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B | 1 |
Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D | 1 |
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
Bonnet, R; Caniça, M; Manageiro, V; Mendonça, N | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
Beceiro, A; Bou, G; Cisneros, JM; Fernández-Cuenca, F; Martínez-Martínez, L; Pachón, J; Pascual, A; Pérez, A; Rodríguez-Baño, J; Vila, J | 1 |
Bonnet, R; Brisabois, A; Cloeckaert, A; Doublet, B; Fabre, L; Granier, SA; Robin, F; Weill, FX | 1 |
Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Ghori, S; Griggs, DJ; Johnson, MM; Mott, A; Peake, L; Piddock, LJ | 1 |
Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D | 1 |
Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A | 1 |
Girlich, D; Nordmann, P; Poirel, L | 1 |
Bethel, CR; Bonomo, RA; Distler, AM; Kasuboski, C; Papp-Wallace, KM; Taracila, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Bonomo, RA; Distler, AM; Endimiani, A; Hornick, JM; Hujer, AM; Hujer, KM; Papp-Wallace, KM; Taracila, M | 1 |
Nordmann, P; Poirel, L; Rodríguez-Martínez, JM; Ronco, E | 1 |
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
Hohl, P; von Graevenitz, A; Zollinger-Iten, J | 1 |
Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N | 1 |
Benz, J; Kaehler, D; Köppel, R | 1 |
Ben Yaghlane-Bouslama, H; Boujnah, A; Kallel, H; Labia, R; Petit, A; Sirot, J; Sofer, L | 1 |
Bawdon, RE; Dax, JB; Gilstrap, LC; Maberry, MC; Sobhi, S; Trimmer, KJ | 1 |
Carlin, SA; Johnson, CE; Marchant, CD; Shurin, PA | 1 |
Arlet, G; Ben Hassen, A; Ben Redjeb, S; Grimont, F; Hammami, A; Philippon, A; Rekik, A | 1 |
Amyes, SG; Marriott, MS; Payne, DJ | 1 |
Bergeron, MG; L'Ecuyer, J; Provencher, P; Tremblay, LD | 1 |
Denis, P; Gehanno, P; Gojon, D; Hoareau, J; Jacquet, P; Kosowski, A; Pascarel, J; Taillebe, M | 1 |
Acar, JF; Coutrot, A; Ferré, B; Gutmann, L; Kitzis, MD | 1 |
Beumer, HM | 1 |
Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
Escoubas, J; Fouche, J; Mormede, M; Texier-Maugein, J | 1 |
Barry, AL; Fuchs, PC; Jones, RN | 1 |
Hunter, PA; Wilson, JM | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
Acred, P; McColm, AA; Ryan, DM; Shelley, E | 1 |
Bernlohr, RW; Fields, PI; Saha, AL; Schreier, HJ | 1 |
Fu, KP; Neu, HC | 1 |
Clarke, AM; Zemcov, SJ | 1 |
Jones, R; Satishchandran, V; Shapiro, T; Suh, B; Truant, AL | 1 |
Rahal, K; Reghal, A | 1 |
Amicosante, G; Franceschini, N; Oratore, A; Perilli, M; Segatore, B; Setacci, D | 1 |
Anderson, G; Boldiston, C; O'Brien, P; Woods, S | 1 |
Alonso, JM; Fournier, JL; Jacolot, AC; Petitjean, OJ; Ramisse, F; Scavizzi, MR; Szatanik, M | 1 |
Bajaksouzian, S; Jacobs, MR | 1 |
García-Rodríguez, JA | 1 |
Keane, CT; McCarthy, ND; McConkey, SJ | 1 |
Alberty, J; Hermann, W; Stoll, W | 1 |
Barrio, JL; Dedéu, JM; Gómez, C; Guarner, C; Kolle, L; Miñana, J; Novella, MT; Ortiz, J; Ricart, E; Sàbat, M; Sola-Vera, J; Soriano, G | 1 |
Bégué, CR; Bégué, RE; English, MR; Perez Mato, S | 1 |
Louie, M; Simor, AE; Watt, C | 1 |
Bedenic, B; Boras, A; Haechler, H; Randegger, C | 1 |
Godová, T; Hulínská, D; Janovská, D | 1 |
Arr, M; Flautner, L; Pulay, I; Williams, C; Zsirka, KA | 1 |
Anderson, GJ; Biddle, JW; Brittain, KL; Hubert, SK; McGowan, JE; Oliver, A; Raney, PM; Rasheed, JK; Steward, CD; Tenover, FC; Williams, PP | 1 |
Chong, Y; Inoue, M; Lee, K; Lim, JK; Okamoto, R; Yong, D; Yum, J | 1 |
Ficari, F; Mazzei, T; Mazzoni, P; Novelli, A; Tonelli, F | 1 |
Díaz de Tuesta Chow-Quan, AM; Dimas Nuñez, JF; Geijo Martínez, MP; Gómez Criado, C; Herranz, CR; Saiz García, F | 1 |
Høiby, N; Walther-Rasmussen, J | 1 |
Akova, M; Hasçelik, G; Metan, G; Zarakolu, P | 2 |
Bilewska, A; Dukaczewska, A; Goławski, C; Kicman, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J; Serafin, I | 1 |
Beceiro, A; Bonnet, R; Bou, G; Cartelle, M; Mallo, S; Pérez, A; Pérez-Llarena, FJ; Romero, A; Villanueva, R | 1 |
Grinholc, M; Kaminska-Pabich, A; Kurlenda, J | 1 |
Deb, M; Gaind, R; Mohanty, S; Ranjan, R | 1 |
Kechrid, A; Mercuri, PS; Power, P; Réjiba, S | 1 |
Baquero, F; Cantón, R; Galán, JC; Novais, A; Ripoll, A; Rodríguez-Domínguez, MJ; Turrientes, MC | 1 |
Chong, Y; Docquier, JD; Jeong, SH; Lee, K; Rossolini, GM; Yong, D; Yum, JH | 1 |
Chitnis, DS; Chitnis, S; Hemvani, N; Katara, G | 1 |
Aubert, V; Baserni, MN; Jugo, MB; Villar, HE | 1 |
Fang, ZL; Huang, X; Huang, YM; Qing, Y; Tian, GB; Zhang, XF | 1 |
Ardıç, N; Duyan, S; Kılıç, A; Yılmaz, S | 1 |
Cai, W; Chen, X; Dong, C; Fu, Y; Huang, Y; Li, Y; Song, W; Sun, R; Wu, Z; Zhang, F; Zhang, W; Zhao, J | 1 |
Sharma, AK; Vats, P | 1 |
Buter, RGJ; Gonggrijp, MA; Heuvelink, AE; Lam, TJGM; Ter Bogt-Kappert, CC; van Schaik, G; Velthuis, AGJ | 1 |
Furuhashi, K; Hamada, E; Ishikawa, J; Iwaizumi, M; Maekawa, M; Nagao, Y; Nagura, O; Nanba, T; Ota, Y; Yamanaka, K | 1 |
Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T | 1 |
Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I | 1 |
Jiang, Y; Kuang, L; Lee, M; Shi, H; Yan, L; Zhou, W | 1 |
2 review(s) available for clavulanic acid and cefotaxime
Article | Year |
---|---|
Drug-resistant Streptococcus pneumoniae spinal epidural abscess in a toddler.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Cefotaxime; Cephalosporins; Child, Preschool; Clavulanic Acid; Drug Resistance, Microbial; Epidural Abscess; Humans; Male; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enzyme Inhibitors; Gene Transfer, Horizontal; Monobactams; Penicillanic Acid; Penicillins; Phylogeny; Sulbactam; Tazobactam | 2004 |
9 trial(s) available for clavulanic acid and cefotaxime
Article | Year |
---|---|
[The effectiveness of preventive use of antibiotics in Cesarean section with a single dose: comparison of cefotaxime with amoxicillin plus clavulanic acid].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Cesarean Section; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Pregnancy; Premedication; Prospective Studies; Puerperal Infection; Risk Factors; Surgical Wound Infection | 1992 |
Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".
Topics: Acute Disease; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Combinations; Efficiency; Enzyme Inhibitors; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media; Punctures; Streptococcus pneumoniae; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane | 1992 |
Short-course cefotaxime compared with five-day co-amoxyclav in acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Cefaclor; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media | 1990 |
Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
Topics: Adult; Amoxicillin; Bacterial Infections; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections | 1989 |
A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Cost-Benefit Analysis; Gastrointestinal Diseases; Humans; Penicillins; Prospective Studies; Surgical Wound Infection; Ticarcillin | 1996 |
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Penicillins; Treatment Outcome | 2000 |
[Antibiotic prophylaxis for high risk patients undergoing cholecystectomy].
Topics: Age Factors; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefamandole; Cefotaxime; Cefuroxime; Cephalosporins; Cholecystectomy; Clavulanic Acid; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Penicillins; Postoperative Complications; Reoperation; Risk; Risk Factors; Surgical Wound Infection; Treatment Outcome | 2000 |
Amoxicillin/clavulanic acid versus cefotaxime for antimicrobial prophylaxis in abdominal surgery: a randomized trial.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cefotaxime; Clavulanic Acid; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Postoperative Complications; Surgical Wound Infection | 2002 |
[Levofloxacin versus beta-lactamic therapy in community acquired pneumonia that requires hospitalization].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Clavulanic Acid; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2002 |
83 other study(ies) available for clavulanic acid and cefotaxime
Article | Year |
---|---|
Cephalosporin 3'-phloroglucide esters and 7-(phloroglucidamido) cephalosporins as novel antibacterial agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Benzhydryl Compounds; Benzophenones; beta-Lactamase Inhibitors; Candida albicans; Cephalosporins; Esters; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Molecular Structure; Pseudomonas aeruginosa; Staphylococcus aureus | 1997 |
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Evolution, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation | 2007 |
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data | 2007 |
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Plasmids; Sequence Analysis, DNA | 2007 |
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Hydrolysis; Kinetics; Microbial Sensitivity Tests; Spectrophotometry, Ultraviolet | 2007 |
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet | 2007 |
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalysis; Ceftazidime; Clavulanic Acid; Escherichia coli; Escherichia coli Proteins; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam | 2007 |
First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.
Topics: Aeromonas; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; France; Integrons; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Substrate Specificity | 2007 |
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Kinetics; Klebsiella pneumoniae | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Genetic variability among ampC genes from acinetobacter genomic species 3.
Topics: Acinetobacter; Acinetobacter baumannii; Amino Acid Sequence; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Escherichia coli; Genes, Bacterial; Genetic Variation; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Homology, Amino Acid; Spain | 2009 |
Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cardiidae; Ceftazidime; Ceftriaxone; Cephalosporin Resistance; Electrophoresis, Gel, Pulsed-Field; France; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Salmonella enterica; Serotyping | 2009 |
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
Topics: Amino Acid Sequence; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Campylobacter jejuni; Carbenicillin; Cephalosporins; Chickens; Cloxacillin; Isoelectric Focusing; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Piperacillin; Polymerase Chain Reaction; Sequence Alignment; Ticarcillin | 2009 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Penicillanic Acid; Spectrometry, Mass, Electrospray Ionization; Sulbactam; Tazobactam | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporinase; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Hydrogen Bonding; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Mutagenesis, Site-Directed; Penicillanic Acid; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Sulbactam; Tazobactam | 2010 |
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Mutagenesis, Site-Directed | 2010 |
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin | 2010 |
In vitro activities of Ro 40-6890 against 164 predominantly intestinal members of the families Enterobacteriaceae and Vibrionaceae.
Topics: Amoxicillin; Cefadroxil; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Intestines; Microbial Sensitivity Tests; Vibrionaceae | 1992 |
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1992 |
[Identification of a new penicillinase in a Klebsiella pneumoniae strain of which a mutant also produces an esterase hydrolyzing cephalothin and cefotaxime].
Topics: Acetylesterase; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Penicillin Resistance; Penicillinase; Penicillins | 1992 |
Antibiotic concentration in maternal blood, cord blood and placental tissue in women with chorioamnionitis.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Chorioamnionitis; Chromatography, High Pressure Liquid; Clavulanic Acid; Clavulanic Acids; Female; Fetal Blood; Humans; Placenta; Pregnancy; Regression Analysis; Sulbactam; Ticarcillin | 1992 |
Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase.
Topics: Acute Disease; beta-Lactamases; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Synergism; Feces; Gastroenteritis; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Salmonella; Salmonella Infections; Tunisia | 1991 |
Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Conjugation, Genetic; Drug Resistance, Microbial; Escherichia coli; Humans; Hydrolysis; Infant, Newborn; Klebsiella; Penicillins; Plasmids | 1990 |
Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Canada; Cefaclor; Cefamandole; Cefazolin; Cefotaxime; Cefuroxime; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Haemophilus influenzae; Rifampin; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Cephalosporinase; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Ticarcillin | 1989 |
[Sensitivity to clavulanic acid of Escherichia coli isolated at the Henri Mondor hospital in 1986 according to phenotypes of beta-lactam antibiotic resistance].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbenicillin; Cefotaxime; Cephalothin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Microbial Sensitivity Tests; Penicillin Resistance; Phenotype | 1988 |
[Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; beta-Lactamases; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Doxycycline; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Respiratory Tract Infections | 1988 |
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Topics: Bacteria, Aerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Microbial Sensitivity Tests; Sulbactam | 1987 |
Comparative antibacterial effects of amoxycillin, amoxycillin/clavulanic acid and cefotaxime against Enterobacteriaceae as determined by turbidimetry, morphology and viable count.
Topics: Amoxicillin; Bacteriological Techniques; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Escherichia coli; Klebsiella pneumoniae; Microscopy, Electron, Scanning; Nephelometry and Turbidimetry | 1986 |
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
Topics: Amoxicillin; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalexin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Escherichia coli; In Vitro Techniques; Pseudomonas; Staphylococcus | 1986 |
Evaluation of ceftazidime in experimental Klebsiella pneumoniae pneumonia: comparison with other antibiotics and measurement of its penetration into respiratory tissues and secretions.
Topics: Amoxicillin; Animals; Body Fluids; Cefotaxime; Cefotiam; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Pleura; Pneumonia; Tissue Distribution; Trachea | 1986 |
Use of the beta-lactamase inhibitor clavulanic acid in the isolation of auxotrophic mutants of Bacillus licheniformis.
Topics: Bacillus; beta-Lactamase Inhibitors; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Mutation | 1984 |
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam | 1981 |
Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1984 |
In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefotaxime; Ceftazidime; Ceftriaxone; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Sulbactam; Tazobactam | 1995 |
[A nosocomial epidemic of Salmonella mbandaka which produces various broad spectrum beta-lactamases: preliminary results].
Topics: Algeria; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporin Resistance; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Cross Infection; Disease Outbreaks; DNA, Bacterial; Enzyme Inhibitors; Humans; Infant; Infant, Newborn; Plasmids; Salmonella; Salmonella Infections | 1994 |
In vitro activity of cefodizime (HR-221) in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Stability; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 1993 |
Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia, Bacterial; Tazobactam; Ticarcillin | 1996 |
Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Culture Media; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Osmolar Concentration; Penicillins | 1997 |
Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Humans; Penicillins; Spain; Urinary Tract Infections | 1998 |
Primary peritonitis due to nonenteric salmonellae.
Topics: Adolescent; Aged; Amoxicillin; Cefotaxime; Ciprofloxacin; Clavulanic Acid; Fatal Outcome; Humans; Male; Metronidazole; Peritonitis; Salmonella; Salmonella Infections; Salmonella typhimurium; Treatment Outcome | 1999 |
[Interesting case no. 25. Cervical tuberculous lymphadenitis].
Topics: Adult; Amoxicillin; Cefotaxime; Cephalosporins; Clavulanic Acid; Clindamycin; Diagnostic Techniques, Surgical; Drug Combinations; Humans; Male; Tuberculosis, Lymph Node | 1999 |
Evaluation of stability of cefotaxime (30-microg) and ceftazidime (30-microg) disks impregnated with clavulanic acid (10 microg) for detection of extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Stability; Escherichia coli; Evaluation Studies as Topic; Microbial Sensitivity Tests; Time Factors | 2000 |
Comparison of five different methods for detection of SHV extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Cefotaxime; Ceftriaxone; Clavulanic Acid; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2001 |
Sensitivity of Borrelia burgdorferi strains isolated in the Czech Republic.
Topics: Amoxicillin; Anti-Bacterial Agents; Borrelia burgdorferi Group; Cefotaxime; Ceftriaxone; Clavulanic Acid; Czech Republic; Doxycycline; Humans; In Vitro Techniques; Lyme Disease; Microbial Sensitivity Tests; Penicillin G; Species Specificity | 2001 |
Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
Topics: Algorithms; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Clavulanic Acid; Humans; Isoelectric Focusing; Klebsiella pneumoniae; Laboratories; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2001 |
Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Clavulanic Acid; Drug Stability; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence | 2001 |
[Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Sensitivity and Specificity | 2005 |
[High effectiveness of the method with cefpirome in detection of extended-spectrum beta-lactamases in different species of gram-negative bacilli].
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cefpirome; Cephalosporins; Clavulanic Acid; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Species Specificity | 2006 |
[Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefotaxime; Ceftazidime; Clavulanic Acid; Cross Infection; Drug Combinations; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence; Turkey | 2007 |
Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalothin; Chromatography, Affinity; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Inhibitory Concentration 50; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed | 2008 |
Neonatal intrauterine infection with Neisseria meningitidis B.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cesarean Section; Clavulanic Acid; Female; Fever; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Male; Maternal Exposure; Meningitis, Meningococcal; Neisseria meningitidis, Serogroup B; Penicillin G; Pregnancy; Pregnancy Complications, Infectious; Respiratory Tract Infections; Seizures; Treatment Outcome | 2010 |
Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus mirabilis; Sensitivity and Specificity | 2009 |
Emergence and dominance of CTX-M-15 extended spectrum beta-lactamase among Escherichia coli isolates from children.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Cefotaxime; Ceftazidime; Child; Clavulanic Acid; Disk Diffusion Antimicrobial Tests; DNA Transposable Elements; DNA, Bacterial; DNA, Intergenic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Humans; Plasmids; Polymerase Chain Reaction; Tunisia | 2011 |
In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Clavulanic Acid; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Evolution, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Penicillanic Acid; Piperacillin; Plasmids; Selection, Genetic; Tazobactam | 2011 |
Biochemical characterization of the TEM-107 extended-spectrum β-lactamase in a Klebsiella pneumoniae isolate from South Korea.
Topics: Adolescent; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Clavulanic Acid; Conjugation, Genetic; Escherichia coli; Female; Humans; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Republic of Korea | 2011 |
Augmentation in zone of inhibition of cefoperazone/cefoperazone+ sulbactum compares well with the clinical laboratory standard institute standard extended spectrum beta-lactamase detection method as well as the polymerase chain reaction method.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftazidime; Clavulanic Acid; Drug Combinations; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sulbactam | 2011 |
Maternal carriage of extended-spectrum beta-lactamase-producing Escherichia coli isolates in Argentina.
Topics: Anti-Bacterial Agents; Argentina; beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Gestational Age; Humans; Maternal Exposure; Microbial Sensitivity Tests; Pregnancy; Prevalence; Vagina | 2013 |
CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Clavulanic Acid; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mutant Chimeric Proteins; Plasmids; Urinary Tract Infections | 2014 |
[Rapid detection of extended-spectrum beta-lactamases by flow cytometry method].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Combinations; Enterobacteriaceae; Flow Cytometry; Humans | 2015 |
Synergistic effects of baicalein with cefotaxime against Klebsiella pneumoniae through inhibiting CTX-M-1 gene expression.
Topics: Alkaloids; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Clavulanic Acid; DNA, Bacterial; Drug Synergism; Drugs, Chinese Herbal; Escherichia coli Proteins; Flavanones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Matrines; Microbial Sensitivity Tests; Quinolizines; RNA, Messenger | 2016 |
Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Southern; Cefotaxime; Cephalosporins; Clavulanic Acid; Humans; Isoelectric Focusing; Kinetics; Mycobacterium tuberculosis; Polymerase Chain Reaction; Tuberculosis | 2019 |
Prevalence of extended-spectrum and AmpC β-lactamase-producing Escherichia coli in Dutch dairy herds.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cattle; Cattle Diseases; Cefotaxime; Cefoxitin; Clavulanic Acid; Dairying; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Netherlands; Prevalence | 2019 |
Detection of extended-spectrum β-lactamases producing Enterobacteriaceae using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry based MBT STAR-BL software module with β-lactamase inhibition assay depends on the bacterial stra
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Clavulanic Acid; Enterobacteriaceae; Humans; Hydrolysis; Microbial Sensitivity Tests; Software; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam | 2019 |
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing | 2023 |
Antibiotic Resistance of Hemophilus influenzae Isolated from Children in Southwest China.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Child; Child, Preschool; Clavulanic Acid; Drug Resistance, Microbial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Retrospective Studies | 2023 |